Figure 3. Subgroup analysis of risk stratification treatments and outcomes of t(8;21) AML. (A,D) Relapse. (B,E) DFS. (C,F) OS. HSCT, hematopoietic stem cell transplantation; CT, chemotherapy.
Figure 3

Subgroup analysis of risk stratification treatments and outcomes of t(8;21) AML. (A,D) Relapse. (B,E) DFS. (C,F) OS. HSCT, hematopoietic stem cell transplantation; CT, chemotherapy.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal